LEADER 01438nam  2200349Ia 450 
001 9910696917903321
005 20230902161951.0
035   $a(CKB)5470000002383716
035   $a(OCoLC)560600003
035   $a(EXLCZ)995470000002383716
100   $a20100319d1996      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aDemonstration of comparability of human biological products, incuding therapeutic biotechnology-derived products$b[electronic resource]
210  1$aRockville, MD :$cU.S. Food and Drug Administration, Center for Biologics Evaluation and Research :$cCenter for Drug Evaluation and Research,$d[1996]
215   $a1 electronic resource
300   $a"April 1996."
320   $aIncludes bibliographical references.
517 1 $aFDA guidance concerning demonstration of comparability of human biological products, including therapeutic biotechnology-derived products
606   $aBiologicals$zUnited States
615  0$aBiologicals
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910696917903321
996   $aDemonstration of comparability of human biological products, incuding therapeutic biotechnology-derived products$93143295
997   $aUNINA